Aller au contenu
For patients

At the clinic

At home

On line

Health assessments

Our programs

Pricing

Career

Contact us

French

English
Make an appointment

514 606-3350

info@cliniqueomicron.ca​

FR / EN
Logo - Clinique Omicron
Make an appointment
Hematology & Clinical Biochemistry & Family Medicine

Mean Platelet Volume

The mean platelet volume (MPV) is a platelet parameter automatically calculated by the complete blood count (CBC) that measures the average volume of a platelet in femtoliters (fl). Its normal value is 7.5 to 12.5 fl depending on the laboratory, with variations depending on the type of analyzer used, the anticoagulant (EDTA vs. citrate), and the analysis delay (platelets swell in EDTA over time). The MPV indirectly reflects the activity of medullary megakaryocytic production: large platelets (high MPV) are metabolically more active, richer in granules, and more thrombogenic, generally corresponding to young platelets recently released in response to increased peripheral destruction or consumption—such as in immune thrombocytopenia (ITP), acute hemorrhage, or mechanical destruction. Conversely, small platelets (low MPV) indicate insufficient medullary production (aplastic anemia, myelodysplasia, chemotherapy, medullary infiltration) where the bone marrow cannot produce enough platelets in response to thrombocytopenia. This distinction between thrombocytopenia due to increased destruction (high MPV, reactive marrow) and thrombocytopenia due to insufficient production (low MPV, failing marrow) is clinically and therapeutically fundamental: in the former case, the marrow is functional and treatment aims to reduce destruction; in the latter case, the marrow is failing and the medullary cause must be treated. The MPV should always be interpreted with the total platelet count, the complete CBC, and the clinical context, as it can be falsely normal in mixed forms or during pre-analytical variations.

Normal Values and Interpretation

  • Normal VPM 7.5–12.5 fl (depending on laboratory and automated analyzer) + normal-sized platelets + balanced bone marrow production
  • High VPM (>12.5 fL) — macrothrombocytes: Large and young platelets → signal of increased reactive medullary production in response to peripheral destruction or consumption + or intrinsic abnormality of megakaryocytes
  • VPM low (<7.5 fL) — microthrombocytes: small platelets → insufficient or defective bone marrow production + or Wiskott-Aldrich syndrome (pathognomonic microthrombocytes)
  • Frequent pre-analytical artifact: platelets swell in EDTA over time → MPV artificially increases if analysis is delayed >1 hour → collect in citrate or analyze immediately for borderline MPV

High VPM — diagnostic orientation

Condition VPM Plaquettes Mechanism
Immune thrombocytopenic purpura (ITP) Elevated ++ (>12 fl) Basses (<100 G/L) Peripheral destruction by anti-platelet autoantibodies → megakaryocytes compensate → release young giant platelets
Thrombocytopenia due to mechanical destruction (DIC + PT + HUS) Raised Very low Fragmentation and peripheral consumption → reactive medullary compensation
Acute hemorrhage Elevated (transient) Normal to low (depending on importance) Release of young platelets in response to losses
Hypothyroidism Raised Variables Imprecise mechanism — changes in thrombopoiesis + larger and more active platelets
Metabolic syndrome + diabetes + obesity Slightly elevated Normal Chronic platelet activation + inflammation + oxidative stress → residual cardiovascular risk marker (epidemiological association)
Reactive thrombocytosis (inflammation + iron deficiency) Variable, often normal or slightly elevated Elevated (>450 g/L) Stimulation of thrombopoiesis by IL-6 and thrombopoietin in an inflammatory context

VPM base — diagnostic orientation

  • Aplastic anemia VPM low + pancytopenia + collapsed reticulocytes → empty marrow → myelogram essential + treatment: cyclosporine + ALS (anti-lymphocyte serum) + stem cell transplant
  • Myelodysplasia: VPM (dysplastic platelets) + macrocytosis + variable cytopenias → bone marrow biopsy + karyotype → risk of transformation into AML
  • Bone marrow infiltration (metastases + lymphomas + leukemias): hematopoietic bone marrow replacement → thrombocytopenia + low MPV + leucoerythroblastosis on peripheral blood smear (presence of erythroblasts + myelocytes in peripheral blood)
  • Chemotherapy + myelosuppressive radiotherapy Direct toxicity to megakaryocytes → thrombocytopenia + low transient MPV + recovery in 2–3 weeks after cessation
  • Wiskott-Aldrich Syndrome: X-linked rare disease + pathognomonic microthrombocytes (very low MPV + 5-fluorocytosine + eczema + combined immunodeficiency + severe thrombocytopenia
  • B12 and folate deficiency Megaloblastic dysthrombopoiesis → small platelets + dysfunctional + often in context of pancytopenia
ℙ️ The combination of thrombocytopenia + high MPV points towards peripheral destruction (ITP + DIC + TTP) with a reactive bone marrow—in this case, the bone marrow is functional and releases young, large platelets as compensation. Conversely, the combination of thrombocytopenia + low MPV points towards a failure of medullary production (aplastic anemia + myelodysplasia + infiltration + chemotherapy)—in this case, the bone marrow is failing and cannot compensate for the thrombocytopenia. This distinction directly guides the decision for a bone marrow aspirate if there is low MPV + unexplained thrombocytopenia, versus pursuing the search for a cause of peripheral destruction if MPV is high.
Medical consultation recommended

Consult a doctor if thrombocytopenia is discovered on a complete blood count – whether it's accompanied by a high MPV (likely peripheral destruction) or a low MPV (likely bone marrow failure) + especially if the platelet count is below 50 G/L + or if bleeding signs are present (petechiae + bruising + mucosal bleeding). Severe thrombocytopenia (<20 G/L) with active bleeding signs is a medical emergency. For a complete assessment of platelet abnormalities and MPV interpretation, Clinique Omicron offers medical consultations at its service points in Quebec and via telemedicine. To make an appointment, visit cliniqueomicron.ca.

Consult at Clinique Omicron

Clinique Omicron's doctors and nurse practitioners (NPs) interpret the MPV in its clinical context and alongside the complete blood count (CBC). They distinguish between thrombocytopenia due to peripheral destruction (high MPV - ITP + DIC) and thrombocytopenia due to bone marrow failure (low MPV - aplasia + myelodysplasia). They prescribe a blood smear for confirmation and a targeted etiological workup, refer to hematology for a bone marrow biopsy if a medullary cause is suspected, and manage chronic thrombocytopenia. Consultations are available at several service points in Quebec and via telemedicine. To make an appointment, visit cliniqueomicron.ca.

The content of this page is provided for informational purposes only and does not substitute for medical or hematological advice. MPV is subject to significant pre-analytical variations — platelets swell in EDTA over time, artificially increasing MPV if analysis is delayed. An isolated high or low MPV without thrombocytopenia or other CBC abnormalities is rarely clinically significant.

Omicron Clinic

Need to consult a doctor?

Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.

Insurance receipts. 7j/7. No family doctor required.

Skip to content